Weight-loss drugs could transform healthcare by slowing aging, scientists say
Weight-loss drugs such as semaglutide, marketed under the brand names Wegovy and Ozempic, are set to revolutionise healthcare by potentially slowing down the ageing process and extending healthy lifespans, according to leading scientists. This bold assertion follows recent studies presented at the European Society of Cardiology Conference in London. Previous
Blueberries show promise in reducing dementia risk, US study finds
Dementia, a debilitating condition affecting an estimated 900,000 people in the UK, is often marked by memory loss and confusion, with Alzheimer’s disease being the most prevalent form. However, recent research has shed light on the potential role of certain foods in either increasing or reducing the risk of developing
